Components:
Method of action:
Treatment option:
Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 09.04.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Aflogol
Aminobenzoic Acid
Viral conjunctivitis, keratoconjunctivitis, keratouveitis caused by Herpes simplex, Herpes zoster, adenovirus, keratopathies of infectious, post-traumatic and post-operative genesis, dystrophic diseases of the retina and cornea, burns and eye injuries, discomfort associated with eye strain and fatigue, including when wearing contact lenses.
Local: instill in the conjunctival sac 1-2 drops 3-8 times a day. After clinical recovery, instillation is continued for 2 drops 3 times a day for 7 days.
Subconjunctival, parabulbar, retrobulbar: injections of 0.3-0.5 ml. The course of 3-15 injections. For superficial forms of herpetic keratitis, injections are made after 1 day or after 2-3 days in combination with instillations of 2 drops 4-8 times a day, depending on the course of the disease. In deep forms of herpetic keratitis, injections are first carried out 1 time daily, then after 2-3 days in combination with instillation of 2 drops 4-8 times, depending on the severity and dynamics of the disease. After clinical recovery, in both forms of the disease, instillation is continued for 2 drops per day for 7-10 days.
Privateline: for retinal dystrophy-injections of 1 ml, the course of treatment — 10 injections.
Hypersensitivity to the components of the drug. To date, data from clinical trials regarding the use of the drug during pregnancy, lactation, and in children are not available. However, the drug can be used if the intended benefit exceeds the possible risk.
Rarely conjunctival hyperemia, local allergic reactions.
Accidental ingestion does not pose a risk of unwanted side effects.
When administered topically, paraaminobenzoic acid is rapidly absorbed and has a therapeutic effect.
- Other immunomodulators
- Antiviral drugs (excluding HIV)
- Ophthalmic products
In combination with modified nucleosides (acyclovir, ganciclovir, fludarabine phosphate, etc.) and antibiotics, the therapeutic effect is enhanced. Do not use simultaneously with sulfa drugs (sulfacetamide), with Encada for local use.
